Overview
- 1 FDA inspection is on record.
- 1 inspection produced a Form 483.
- The most recent recorded inspection date is 2022-07-21.
At a glance
Inspections
1
Form 483s
1
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 7 Jul 2022 – 21 Jul 2022 | Biologics | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
21 Jul 2022
21 CFR 1271.47(a)
Testing, screening, donor eligibility procedures
Cited by Yvonne C Wilkes, Creighton T Tuzon
21 Jul 2022
21 CFR 1271.55(c)
Name and personal info on accompanying records
Cited by Yvonne C Wilkes, Creighton T Tuzon
21 Jul 2022
21 CFR 1271.75(a)(1)
Risk factors, clinical evidence
Cited by Yvonne C Wilkes, Creighton T Tuzon
21 Jul 2022
21 CFR 1271.85(a)
Infection with communicable disease agents
Cited by Yvonne C Wilkes, Creighton T Tuzon
Investigators
FDA investigators tied to this site in the record.
Yvonne C Wilkes1 insp.
Creighton T Tuzon1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 1271.47(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.55(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.75(a)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.85(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Akyut Bayrak, MD. A Professional Corporation's 1 Form 483
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat